Risperidone in Treatment-Refractory Schizophrenia

Abstract

Risperidone was better tolerated and more effective in a subset of patients with treatment-refractory schizophrenia. Positive psychotic symptoms and extrapyramidal side effects at baseline appear to be powerful predictors of subsequent response to risperidone.

References

Page 1

	Year	Citations
The Brief Psychiatric Rating Scale John E. Overall, Donald R. Gorham Psychological Reports Psychiatric EvaluationPsychiatryClinical PsychologyPsychologySocial Sciences	1962	10.9K
Clozapine for the Treatment-Resistant Schizophrenic John M. Kane Archives of General Psychiatry	1988	4.1K
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS G. M. Simpson, M. B., GH. B., Acta Psychiatrica Scandinavica NeuropsychologyExtrapyramidal System DisturbancePsychopharmacologyNeuropsychiatryPharmacotherapy	1970	3.2K
A Rating Scale for Drug-Induced Akathisia Thomas R. E. Barnes The British Journal of Psychiatry	1989	2.2K
Risperidone in the treatment of schizophrenia Stephen R. Marder, Richard C. Meibach American Journal of Psychiatry	1994	1.2K
Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. Paul A. J. Janssen, C. J. E. Niemegeers, F. Awouters, Journal of Pharmacology and Experimental Therapeutics	1988	467
Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative study A. Claus, J. Bollen, H. De Cuyper, Acta Psychiatrica Scandinavica Psychotropic MedicationPsychopharmacologyNeuropsychiatryPharmacotherapyRisperidone Versus Haloperidol	1992	295
Risperidone Versus Clozapine in Treatment-Resistant Chronic Schizophrenia: A Randomized Double-Blind Study Guido Bondolfi, H. Dufour, Michel Patris, American Journal of Psychiatry	1998	282
A Controlled Dose Comparison of Haloperidol in Newly Admitted Schizophrenic Patients Theodore Van Putten Archives of General Psychiatry NeuropsychologyPsychotropic MedicationPsychopharmacologyNeuropsychiatryPharmacotherapy	1990	188
Costs and Benefits of Two Doses of Fluphenazine Stephen R. Marder Archives of General Psychiatry NeuropsychologyHealth EconomicsPsychiatryMedicinePsychotic Disorder	1984	182

Page 1